Hacked EMA data reveals potential significant CV19 mRNA batch integrity issues

On December 9, 2020 the European Medical Agency (EMA) was the subject of a cyberattack which was revealed that "COVID-19 medicines and vaccines" [1] data was stolen.  This included "email screenshots, EMA peer review comments, Word documents, PDFs, and PowerPoint presentations”, of which some of those documents related to "the regulatory submission for Pfizer and BioNTech’s COVID-19 vaccine candidate, BNT162b2." [2] Nineteen days after the hack, on December 21, 2020, the EMA granted Conditional Marketing Authorization (CMA) to Pfizer-BioNTech, for the very vaccine in question - which the hack reveals that the EMA regulators had at the time over 100 regulatory objections. On of the biggest objection was reported by a BMJ investigation published on March 10, 2021, that revealed by November 23, 2020 the EMA "regulators had major concerns over unexpectedly low quantities of intact mRNA" ..."between the clinical batches and proposed commercial batches—from around 78% to 55%."  Revealing concerning batch integrity instability. [3, 4, 5, 6]

FDA adds myocarditis warning for mRNA vaccines

On June 25, 2021 the US FDA announced the addition of a warning "to the patient and provider fact sheets for the Moderna and Pfizer-BioNTech COVID-19 vaccines regarding the suggested increased risks of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the tissue surrounding the heart) following vaccination." [1]

CDC acknowledge increasing numbers of myocarditis VAERS reports

The May 27, 2021 CDC's COVID-19 vaccine Adverse Events update first acknowledged myocarditis, stating in "April and May of 2021, there have been increased reports to the Vaccine Adverse Event Reporting System (VAERS) of cases of inflammation of the heart—called myocarditis and pericarditis—happening after COVID-19 vaccination in the United States. These cases have been reported after vaccination with the Pfizer-BioNTech and Moderna COVID-19 vaccines and have mostly been reported in adolescents and young adults." [1]

Patent filed for modified mRNA using pseudouridine

On August 21, 2006 the University of Pennsylvania (UPenn) filed a patent titled "RNA containing modified nucleosides and methods of use thereof", on behalf of the two "inventors" Katalin Kariko and Drew Weissman.   On October 2, 2012 the patent application was granted. The patent is, in part, for the used of "pseudouridine" in create a synthetic mRNA code, which help's the mRNA evade immune detection and last longer than natural mRNA In 2007, the companies mRNA RiboTherapeutics Inc. and CellScript LLC. were established, both connected to Gary Dahl, the director and CEO respectively.  mRNA RiboTherapeutics has an exclusive license to the patent from the Trustees of the University of Pennsylvania. That patent was then sublicensed to CellScript. [2, 3, 4, 5] In 2017, CellScript signed a "Patent Sublicense Agreement" with Moderna on Jun 26, 2017 and the next month mRNA RiboTherapeutics signed one on July 14, 2017 with BioNTech. CellScript, who supplies the modified mRNA [with minimal safety data], went from $7.4M in revenue in 2019 to just under $50M in 2020.  Moderna was to pay "a non-refundable, non-creditable sublicense fee of twenty-two million U.S. dollars ($22,000,000)" by an undisclosed date in 2019, though BioNTech's fees & royalties are not..> READ MORE

AAP/IAC are “challenged” by Trump’s vaccine safety concerns

On April 13, 2017 the American Academy of Pediatrics (AAP) attended an Immunization Action Coalition (IAC) webinar titled "Vaccine Challenges in a New Administration". Their presentation slides show their "alarm and disdain" about President Donald Trump's vaccine safety concerns and they singled out Robert F. Kennedy Jr. (RFK jr) [1, 3] They knew that Trump was "not beholden to the pharmaceutical industry" as he didn't accept funding to get him elected in 2016 [though did for his inauguration], and that he has a history of expressing concerns regarding the regressive health trends in children relative to the increasing vaccine trends. AAP noted on January 10, 2017 that RFK jr met with President-elect Trump at Trump Tower where Kennedy was asked to chair a new commission on “vaccine safety and scientific integrity”, allegedly focused on "autism". That same day AAP issues a statement declaring "vaccines are safe, vaccines are effective, vaccines save lives". [2] At a Feb. 15, 2017 - Press Conference with Robert De Niro and RFK jr before a congressional briefing the next day which was "sparsely attended", RFK jr offered $100K reward to the "first journalist, or other individual, who can find a peer-reviewed scientific study demonstrating that..> READ MORE
Post-jab autopsy findings
Posted inCOVID-19 Vaccines

Autopsy: post-jab

Below are a collection of links specific to autopsy information in relation to the COVID-19 vaccines and COVID-19 the illness. You'll find articles, science papers, interviews, discussions and more which further builds the picture of anomalies and the characterisation of…
23 October 2022Posted inCOVID-19 Vaccines

Pfizer admits their vaccine was not tested for stopping viral transmission

On Monday October 10, 2022 in a COVID hearing in the European Union Parliament, Dutch MEP Rob Roos asked Janine Small, Pfizer's President of International Developed Markets [2, 3, 4, 5] "Was the Pfizer Covid vaccine tested on stopping the transmission of the virus before it entered the market?..." [1] The Pfizer representative's answer was "NO...we had to really move at the speed of science...[and] we had to do everything at risk"! The COVID-19 vaccines were/are mandated to hundreds of millions of people (especially health workers) around the world on the premise that they prevent viral transmission (what a vaccine is supposed to do), and the public were told by public health officials and the media, that no development short-cuts were taken, the vaccines are safe and effective and to roll up their sleeve, get the vaccine "for the greater good" of stopping this virus.  It was all a lie! [6] Pfizer admit in an email to OAN that their trial 'efficacy" endpoints were ONLY to assess: the prevention of confirmed symptomatic COVID-19 infection and the prevention of severe disease "The BNT162b2 trials were not designed to evaluate the vaccine's effectiveness against transmission of SARS-CoV-2" Australia's vaccination advisory board ATAGI..> READ MORE